Central Serous Chorioretinopathy: Multimodal Imaging and Management Options

Area of Science:

• Ophthalmology
• Retinal Diseases
• Choroidal Disorders

Background:

• Central serous chorioretinopathy (CSCR) is an idiopathic maculopathy.
• Characterized by choroidal thickening, retinal pigment epithelial detachment, and subretinal fluid.
• Primarily affects young males, with risk factors including corticosteroid use, type A behavior, and psychological stress.

Observation:

• CSCR is typically self-limiting with a favorable visual prognosis.
• Recurrent or persistent cases can lead to significant visual impairment.
• Potential complications include retinal atrophy, RPE atrophy, and choroidal neovascularization.

Findings:

• Multimodal imaging is crucial for diagnosing and monitoring CSCR.
• Current treatment strategies encompass observation, pharmacotherapy, and surgical interventions.
• Mineralocorticoid receptor antagonists, thermal laser, and photodynamic therapy are key treatment modalities.

Implications:

• Understanding CSCR pathophysiology aids in risk factor management.
• Early diagnosis and appropriate treatment can prevent long-term visual loss.
• Further research into novel therapeutic approaches for refractory CSCR is warranted.